Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Narendra Wajapeyee

Showing results (1-10 of 96) with videos related to

Pageof 10
Sort By:
Methods in Molecular Biology (Clifton, N.J.)|August 10, 2013
Induction of cellular senescence by oncogenic RASRomi Gupta, Narendra Wajapeyee
Cellular and Molecular Life Sciences : CMLS|June 30, 2025
NSD proteins in anti-tumor immunity and their therapeutic targeting by protein degradersSuresh Chava, Narendra Wajapeyee
Current Opinion in Molecular Therapeutics|July 22, 2004
Pharmacogenomics in breast cancer: current trends and future directionsNarendra Wajapeyee, Kumaravel Somasundaram
Cold Spring Harbor Protocols|September 3, 2017
Genome-Wide RNA Interference: Functional Genomics in the Postgenomics EraKaterina Politi, Narendra Wajapeyee
Methods in Molecular Biology (Clifton, N.J.)|November 11, 2016
Transcriptional Analysis-Based Integrative Genomics Approach to Identify Tumor-Promoting Metabolic GenesRomi Gupta, Narendra Wajapeyee
Blood|March 25, 2018
Mechanisms of resistance to EZH2 inhibitors in diffuse large B-cell lymphomasMalik Bisserier, Narendra Wajapeyee
Methods in Molecular Biology (Clifton, N.J.)|December 13, 2018
RNA Modification Regulatory Genes in DNA DamageRadoslav Janostiak, Narendra Wajapeyee
Cancer Biology & Therapy|February 2, 2010
Exploiting cellular senescence to treat cancer and circumvent drug resistanceQin Yan, Narendra Wajapeyee
The Journal of Biological Chemistry|October 11, 2003
Cell cycle arrest and apoptosis induction by activator protein 2alpha (AP-2alpha) and the role of p53 and p21WAF1/CIP1 in AP-2alpha-mediated growth inhibitionNarendra Wajapeyee, Kumaravel Somasundaram
Cancer Research|September 17, 2021
Epigenetic Alterations and Mechanisms That Drive Resistance to Targeted Cancer TherapiesNarendra Wajapeyee, Romi Gupta
Pageof 10

Showing results (1-10 of 96) with videos related to

Sort By:
Pageof 10
Methods in Molecular Biology (Clifton, N.J.)|August 10, 2013
Induction of cellular senescence by oncogenic RASRomi Gupta, Narendra Wajapeyee
Cellular and Molecular Life Sciences : CMLS|June 30, 2025
NSD proteins in anti-tumor immunity and their therapeutic targeting by protein degradersSuresh Chava, Narendra Wajapeyee
Current Opinion in Molecular Therapeutics|July 22, 2004
Pharmacogenomics in breast cancer: current trends and future directionsNarendra Wajapeyee, Kumaravel Somasundaram
Cold Spring Harbor Protocols|September 3, 2017
Genome-Wide RNA Interference: Functional Genomics in the Postgenomics EraKaterina Politi, Narendra Wajapeyee
Methods in Molecular Biology (Clifton, N.J.)|November 11, 2016
Transcriptional Analysis-Based Integrative Genomics Approach to Identify Tumor-Promoting Metabolic GenesRomi Gupta, Narendra Wajapeyee
Blood|March 25, 2018
Mechanisms of resistance to EZH2 inhibitors in diffuse large B-cell lymphomasMalik Bisserier, Narendra Wajapeyee
Methods in Molecular Biology (Clifton, N.J.)|December 13, 2018
RNA Modification Regulatory Genes in DNA DamageRadoslav Janostiak, Narendra Wajapeyee
Cancer Biology & Therapy|February 2, 2010
Exploiting cellular senescence to treat cancer and circumvent drug resistanceQin Yan, Narendra Wajapeyee
The Journal of Biological Chemistry|October 11, 2003
Cell cycle arrest and apoptosis induction by activator protein 2alpha (AP-2alpha) and the role of p53 and p21WAF1/CIP1 in AP-2alpha-mediated growth inhibitionNarendra Wajapeyee, Kumaravel Somasundaram
Cancer Research|September 17, 2021
Epigenetic Alterations and Mechanisms That Drive Resistance to Targeted Cancer TherapiesNarendra Wajapeyee, Romi Gupta
Pageof 10